TLR4 and acute respiratory distress syndrome: The current study is designed to assess the research hypothesis that targeting the eNAMPT/TLR4 inflammatory cascade via an eNAMPT-neutralizing mAb will significantly reduce the severity of preclinical acute lung injury in rat and porcine ARDS/VILI models.